Development of collection process and implant procedure of freshly isolated adipose-derived stromal vascular fraction cells (SVF) in the operation.
| Project/Area Number |
21791631
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Otorhinolaryngology
|
|---|
| Research Institution | Fukushima Medical University |
|---|
Principal Investigator |
SUZUKI Teruhisa Fukushima Medical University, 医学部, 助教 (80508812)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
KOBAYASHI Ken 北海道大学, 大学院・農学研究院, 助教 (30449003)
OKANO Wataru 福島県立医科大学, 医学部, 博士研究員 (10554420)
SUZUKI Masahiro 福島県立医科大学, 医学部, 助教 (90513268)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | 脂肪組織由来細胞 / 多分化能 / 移植 / 再生医療 |
|---|
| Research Abstract |
Freshly isolated adipose-derived stromal vascular fraction cells (SVF) have further advantages over ASC in that they are more readily collected and do not require any culturing prior to use. The study was to identify the enhancement of the regeneration process in the trachea obtained through the use of SVF.SVF show high levels of expression of the stem cell-associated markers CD90, CD105, and CD29, and possess pluripotency like ASC. Our results show that SVF have potential clinical applications as implantable stem cells for use in the regenerative medicine.
|
Report
(3 results)
Research Products
(4 results)
